Crossmark

External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies

Crossref DOI link: https://doi.org/10.1016/j.reumae.2023.11.001

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez-Mendieta, Grisel Guadalupe https://orcid.org/0000-0001-6615-9135
Vega-Morales, David https://orcid.org/0000-0003-0651-2202
Villarreal-Alarcón, Miguel Ángel https://orcid.org/0000-0001-6986-5377
Compean-Villegas, Jesús Eduardo https://orcid.org/0000-0002-2702-6038
Moreno-Arquieta, Ilse Andrea https://orcid.org/0000-0001-6534-7361
Galarza-Delgado, Dionicio Ángel https://orcid.org/0000-0001-9714-2109
License Information

Text and Data Mining valid from 2024-03-01
More Information

This article is maintained by: Elsevier

Article Title: External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2023.11.001

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below